Do you recommend initiating immunosuppression and plasmapheresis in patients with dialysis dependent AKI in the setting of anti-GBM disease who do not have pulmonary involvement?

Do you recommend initiating immunosuppression and plasmapheresis in patients with dialysis-dependent AKI due to anti-GBM disease without pulmonary involvement?

• Yes, I recommend initiating both immunosuppression and plasmapheresis, as they may reduce morbidity and prevent complications despite the risks
• Yes, but only immunosuppression without plasmapheresis, considering the individual patient's condition and potential benefits
• No, I believe the risks of these treatments outweigh the potential benefits in patients with advanced renal-limited disease
• Other